HSandM Magazine

Menu
  • Home
  • About
  • Headlines
  • Top Articles
    • Executive Spotlights
    • Round Tables
    • Industry Trends
    • Talent Trends
    • Great Minds
    • Innovation Showcase
    • Top Industry Lists
    • Why I Work in Healthcare
  • Advertise
  • Agency Directory
  • FREE SUBSCRIPTION!
Menu

HSandM Magazine

Search

Industry Trends

Latest stories

BioPharma’s COVID-19 Response, Market Forecast & M&A

Industry Trends: By the numbers

3 Shares

Beyond COVID-19: Life sciences reimagined

More stories

  • in Industry Trends

    By the numbers

    by hsandm December 14, 2020, 4:32 pm

  • in Industry Trends

    Pharma, Biotech and MedTech Half-Year Review from Evaluate Vantage

    by hsandm November 10, 2020, 6:08 pm

  • in Industry Trends

    Industry Trends: By the numbers

  • in Industry Trends

    The Orphan Drug Outlook

    by hsandm July 1, 2020, 12:00 pm

  • in Industry Trends

    Metrics on Covid-19: Highlights of the Evaluate Vantage Report

    by hsandm May 1, 2020, 12:00 pm

  • in Industry Trends

    INDUSTRY TRENDS: BY THE NUMBERS

    by hsandm May 1, 2020, 12:00 pm

  • in Industry Trends

    Life Science Industry Outlook: 2019 In Review and 2020 Trends to Watch

    by hsandm January 1, 2020, 12:00 pm

  • in Industry Trends

    INDUSTRY TRENDS: BY THE NUMBERS

    by hsandm January 1, 2020, 12:00 pm

  • in Industry Trends

    VANTAGE 2020 PREVIEW

  • in Industry Trends

    INDUSTRY TRENDS: BY THE NUMBERS

    by hsandm November 1, 2019, 12:00 pm

  • in Industry Trends

    KPMG REPORT ON MEDICAL DEVICES 2030

    by hsandm November 1, 2019, 12:00 pm

  • in Industry Trends

    The Secret to Growth? Adapt Your Brand

    by hsandm July 12, 2019, 12:00 am

Load More
Congratulations. You've reached the end of the internet.

Trending Now

  • Headlines

    104 Views0 Comments

    in Headlines

    Novartis has acquired global development and commercial rights to therapeutic applications for iTheranostics’ library of FAP-targeted drugs

    Culver City, CA, March 30, 2021 (PRNewswire) — SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, has executed an assignment agreement that provides exclusive rights to Novartis to develop therapeutic applications for a library of FAP-targeted agents. SOFIE may facilitate clinical supply and is responsible for the commercialization of FAP-targeted PET imaging tracers globally. More

    by hsandm March 30, 2021, 7:02 pm

    Read More

  • Headlines

    102 Views0 Comments

    in Headlines

    Omega Therapeutics to Advance Pipeline and Platform Development with $126 Million in Additional Financing

    Cambridge, MA., March 30, 2021 (PRNewswire) — Omega Therapeutics, Inc. (“Omega”), a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, today announced the closing of an upsized Series C financing of $126 million. Joining Flagship Pioneering, Omega’s institutional founder and principal backer, are leading life science investors including Invus, Fidelity Management & Research Company, funds and accounts managed by BlackRock, Cowen, Point72, Logos Capital, Mirae Asset Capital and other undisclosed new and returning institutional investors. With this financing, Omega has raised over $210 million since its founding in 2017. More

    by hsandm March 30, 2021, 3:19 pm

    Read More

  • Headlines

    251 Views0 Comments

    in Headlines

    Charles River Laboratories Completes the Acquisition of Cognate BioServices

    Wilmington, MA., March 29 2021 (BUSINESS WIRE) — Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of Cognate BioServices, Inc. for approximately $875 million, subject to customary closing adjustments. More

    by hsandm March 29, 2021, 9:09 pm

    Read More

  • Headlines

    725 Views0 Comments

    in Headlines

    Philips sells appliances arm to China’s Hillhouse for €4.37 billion

    Amsterdam, the Netherlands, March 25 2021 (Globe Newswire) – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to sell its Domestic Appliances business, a global leader with EUR 2.2 billion sales in 2020 in kitchen, coffee, garment care and home care appliances, to Hillhouse Capital, a global investment firm focused on helping companies achieve long-term sustainable growth through digital innovation and enablement. The transaction is expected to be completed in the third quarter of 2021, subject to customary closing conditions, including the relevant regulatory approvals. More

    by hsandm March 25, 2021, 12:44 am

    Read More

  • Headlines

    533 Views0 Comments

    in Headlines

    RiverVest Venture Partners Closes $275 Million Life Sciences Fund

    St. Louis, MO, March 24 2021, (Business Wire) — RiverVest Venture Partners, a leading venture capital firm, announced today the closing of its RiverVest Venture Fund V, L.P. (“Fund V”), with $275 million of capital commitments in an oversubscribed fundraise. Fund V brings the firm’s total assets under management to more than $1.6 billion. More

    by hsandm March 24, 2021, 11:23 pm

    Read More

  • Headlines

    934 Views0 Comments

    in Headlines

    Renovacor, Inc. to Merge with Chardan Healthcare Acquisition 2 Corp.

    Philadelphia and New York, March 23, 2021 (PRNewswire) — Renovacor, Inc. (“Renovacor” or the “Company”), an early-stage biotechnology company developing AAV-based gene therapies for devastating cardiovascular and central nervous system (CNS) diseases resulting from BAG3 gene dysfunction, and Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) (“CHAQ”), a special purpose acquisition company or SPAC, sponsored by affiliates of Chardan Capital Markets (“Chardan”), announced today they have entered into a definitive business combination agreement. Upon closing of the transaction, CHAQ will be renamed Renovacor, Inc. and its common stock is expected to be listed on NYSE under the ticker symbol “RCOR” (the “Combined Company”). More

    by hsandm March 23, 2021, 12:32 am

    Read More

Categories

  • Agency Directory
  • Digital Magazine
  • Editorial Board
  • Executive Spotlight
  • Great Minds
  • Headlines
  • Industry Trends
  • Innovation Showcase
  • Leadership
  • Motivideos
  • Round Table
  • Talent Trends
  • Top Industry Lists
  • Uncategorized
  • Why I Work in Healthcare

© 2021 by CL Media, Inc.

  • Home
  • Contact us
  • Privacy Policy
  • Terms of Use
  • Sign Up!
Back to Top
Close
  • Home
  • About
  • Headlines
  • Top Articles
    • Executive Spotlights
    • Round Tables
    • Industry Trends
    • Talent Trends
    • Great Minds
    • Innovation Showcase
    • Top Industry Lists
    • Why I Work in Healthcare
  • Advertise
  • Agency Directory
  • FREE SUBSCRIPTION!
  • facebook
  • twitter
  • instagram
  • pinterest
  • youtube

Log In

Sign In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Back to Login

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

To use social login you have to agree with the storage and handling of your data by this website. %privacy_policy%

Accept

Add to Collection

  • Public collection title

  • Private collection title

No Collections

Here you'll find all collections you've created before.